Healthcare - Biotechnology - NASDAQ - US
$ 0.714
-0.833 %
$ 24.7 M
Market Cap
-0.24
P/E
CASH FLOW STATEMENT
-747 K
OPERATING CASH FLOW
-2.1 M
INVESTING CASH FLOW
2.1 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ocean Biomedical, Inc.
| Net Income | -958 K |
| Depreciation & Amortization | 1.52 M |
| Capital Expenditures | -3 |
| Stock-Based Compensation | 0 |
| Change in Working Capital | 1.74 M |
| Others | -79.3 K |
| Free Cash Flow | -747 K |
Cash Flow
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|
| OPERATING CASH FLOW | ||||
| Net Income | (1.0) | (62.3) | (1.7) | (0.2) |
| Depreciation & Amortization | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0 | 56.5 | 0 | 0 |
| Other Operating Activities | (1.5) | 2.45 K | 0 | 0 |
| Change in Working Capital | 1.7 | 4.7 | 1.6 | 0.2 |
| Cash From Operations | (0.7) | (1.1) | 64 K | 0 |
| INVESTING CASH FLOW | ||||
| Capital Expenditures | 3 | 0 | 0 | 0 |
| Other Items | (2.1) | (107.1) | 0 | 0 |
| Cash From Investing Activities | (2.1) | (107.1) | 0 | 0 |
| FINANCING CASH FLOW | ||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 2.1 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 96 K | 64 K | 0 |
| Cash From Financing Activities | 2.1 | 1.1 | 64 K | 0 |
| CHANGE IN CASH | ||||
| Net Change In Cash | (0.7) | 60 K | 0 | 0 |
| FREE CASH FLOW | ||||
| Free Cash Flow | (0.7) | (1.1) | 64 K | 0 |